tiprankstipranks
IPCA Laboratories Limited (IN:IPCALAB)
:IPCALAB
India Market
Want to see IN:IPCALAB full AI Analyst Report?

IPCA Laboratories Limited (IPCALAB) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

IPCALAB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
IPCA
Laboratories Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IPCALAB Stock 12 Month Forecast

There Are No Analyst Ratings for IN:IPCALAB In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IPCALAB Financial Forecast

IPCALAB Earnings Forecast

Next quarter’s earnings estimate for IPCALAB is ₹10.07 with a range of ₹8.90 to ₹11.30. The previous quarter’s EPS was ₹12.20. IPCALAB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IPCALAB has Performed in-line its overall industry.
Next quarter’s earnings estimate for IPCALAB is ₹10.07 with a range of ₹8.90 to ₹11.30. The previous quarter’s EPS was ₹12.20. IPCALAB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IPCALAB has Performed in-line its overall industry.

IPCALAB Sales Forecast

Next quarter’s sales forecast for IPCALAB is ₹23.78B with a range of ₹23.03B to ₹24.82B. The previous quarter’s sales results were ₹23.93B. IPCALAB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IPCALAB has Performed in-line its overall industry.
Next quarter’s sales forecast for IPCALAB is ₹23.78B with a range of ₹23.03B to ₹24.82B. The previous quarter’s sales results were ₹23.93B. IPCALAB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IPCALAB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Prabhudas Lilladher Analyst forecast on IN:IPCALAB
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹1,710
Buy
21.82%
Upside
Reiterated
02/17/26
Prabhudas Lilladher Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)
ICICI Securities Analyst forecast on IN:IPCALAB
Unknown Analyst
ICICI Securities
Not Ranked
ICICI Securities
₹1,800
Buy
28.23%
Upside
Reiterated
02/17/26
IPCA Laboratories Limited (IPCALAB) Receives a Buy from ICICI Securities
HSBC
₹1,330₹1,375
Hold
-2.05%
Downside
Reiterated
07/17/25
IPCA Laboratories Limited (IPCALAB) Receives a Hold from HSBC
Nomura
₹1,760₹1,590
Buy
13.27%
Upside
Reiterated
06/02/25
Nomura Remains a Buy on IPCA Laboratories Limited (IPCALAB)
Dolat Capital Analyst forecast on IN:IPCALAB
Dolat Capital
Dolat Capital
₹1,750₹1,604
Buy
14.27%
Upside
Reiterated
05/31/25
Dolat Capital Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Prabhudas Lilladher Analyst forecast on IN:IPCALAB
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹1,710
Buy
21.82%
Upside
Reiterated
02/17/26
Prabhudas Lilladher Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)
ICICI Securities Analyst forecast on IN:IPCALAB
Unknown Analyst
ICICI Securities
Not Ranked
ICICI Securities
₹1,800
Buy
28.23%
Upside
Reiterated
02/17/26
IPCA Laboratories Limited (IPCALAB) Receives a Buy from ICICI Securities
HSBC
₹1,330₹1,375
Hold
-2.05%
Downside
Reiterated
07/17/25
IPCA Laboratories Limited (IPCALAB) Receives a Hold from HSBC
Nomura
₹1,760₹1,590
Buy
13.27%
Upside
Reiterated
06/02/25
Nomura Remains a Buy on IPCA Laboratories Limited (IPCALAB)
Dolat Capital Analyst forecast on IN:IPCALAB
Dolat Capital
Dolat Capital
₹1,750₹1,604
Buy
14.27%
Upside
Reiterated
05/31/25
Dolat Capital Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IPCA Laboratories Limited

3 Months
OpenAI Health Care INTipRanks - OpenAI
Success Rate
0/2 ratings generated profit
0%
Average Return
-0.55%
Copying OpenAI Health Care IN's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -0.55% per trade.
1 Year
Success Rate
2/2 ratings generated profit
100%
Average Return
+7.10%
Copying Saion Mukherjee's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +7.10% per trade.
2 Years
Success Rate
2/2 ratings generated profit
100%
Average Return
+10.90%
Copying Saion Mukherjee's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +10.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IPCALAB Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
0
2
2
2
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
2
2
2
0
In the current month, IPCALAB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IPCALAB average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

IPCALAB Stock Forecast FAQ

What is IN:IPCALAB’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:IPCALAB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:IPCALAB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IPCA Laboratories Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is IPCA Laboratories Limited’s share price target?
      Currently, no data Available
      What do analysts say about IPCA Laboratories Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of IPCA Laboratories Limited?
      To buy shares of IN:IPCALAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.